Drugs for Mumps (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 64)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Vaccines |
|
Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 |
|
|
|
2 |
|
Antibodies |
|
Phase 4,Phase 2,Phase 1 |
|
|
|
3 |
|
Immunoglobulins |
|
Phase 4,Phase 2,Phase 1 |
|
|
|
4 |
|
Pharmaceutical Solutions |
|
Phase 4,Phase 3,Phase 2 |
|
|
|
5 |
|
Heptavalent Pneumococcal Conjugate Vaccine |
|
Phase 4,Phase 3,Phase 2 |
|
|
|
6 |
|
Liver Extracts |
|
Phase 4 |
|
|
|
7 |
|
Aluminum hydroxide |
Approved, Investigational |
Phase 3,Phase 2 |
|
21645-51-2 |
|
Synonyms:
Aluminium hydroxide
Aluminium hydroxide gel, dried
Aluminium hydroxide, dried
Aluminum hydroxide gel, dried
|
Aluminum hydroxide, dried
Dried aluminium hydroxide
Dried aluminum hydroxide gel
|
|
8 |
|
Tetracycline |
Approved, Vet_approved |
Phase 3,Phase 2 |
|
60-54-8 |
5353990
|
Synonyms:
(-)-Tetracycline
(4S,4aS,5aS,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
60-54-8
64-75-5 (mono-hydrochloride)
6591-49-7
6-Methyl-1,11-dioxy-2-naphthacenecarboxamide
87128_FLUKA
87128_SIGMA
Abramycin
Abricycline
AC-13151
AC1L1KAT
AC1NQXT7
AC1NRDAM
AC1NS4RQ
AC1NSDX8
AC1NTUT2
AC1NUZHL
AC1O52HS
Achromycin
Achromycin (naphthacene derivative)
Achromycin V
Achromycin, naphthacene derivative
Agromicina
Ambramicina
Ambramycin
Amycin
Anhydrotetracycline
BIDD:GT0653
Biocycline
Bio-tetra
BPBio1_000242
Bristaciclin
Bristaciclin .alpha.
Bristaciclina
Bristacycline
BSPBio_000220
BSPBio_001950
C06570
Cefracycline
Cefracycline suspension
Centet (base)
CHEBI:27902
CHEMBL1440
Ciclibion
CID12309720
CID5280962
CID5289435
CID5353990
CID5359245
CID5388997
CID5412
CID5497101
CID6426717
component of Tetrastatin
Copharlan
Criseociclina
Cyclomycin
Cyclopar
Cytome
D00201
DB00759
Democracin
Deschlorobiomycin
DivK1c_000827
Dumocyclin
EINECS 200-481-9
Enterocycline
HMS2090B04
Hostacyclin
HSDB 3188
IDI1_000827
KBio1_000827
KBio2_001514
KBio2_004082
KBio2_006650
KBio3_001450
KBioGR_000783
KBioSS_001514
Lemtrex (base)
Lexacycline
Limecycline
Liquamycin (Veterinary)
Liquamycin, veterinary
LS-187078
LS-93869
|
Medocycline
Mericycline
methyl-1,11-dioxo-2-naphthacenecarboxamide
Micycline
MLS000069728
MolPort-001-794-633
MolPort-003-983-460
MolPort-005-934-198
NCGC00161665-01
nchembio.273-comp1
nchembio.289-comp1
Neocycline
NINDS_000827
NSC 108579
NSC108579
Omegamycin
Orlycycline
Panmycin
Piracaps (base)
Polycycline
Polycycline (antibiotic)
Polycycline (VAN)
Polycycline, antibiotic
Polyotic
Prestwick0_000140
Prestwick1_000140
Prestwick2_000140
Prestwick3_000140
Purocyclina
Resteclin
Robitet
Roviciclina
Sanclomycine
SK-Tetracycline
SMR000058220
Solvocin
SPBio_001457
SPBio_002159
Spectrum_001034
Spectrum2_001329
Spectrum3_000565
Spectrum4_000352
Spectrum5_001112
STOCK1N-42738
Sumycin
Sumycin (TN)
Sumycin syrup
T-125
T3258_SIGMA
Tetrabon
Tetrachel
Tetraciclina
Tetraciclina [INN-Spanish]
Tetra-Co
Tetracycl
Tetracyclin
tetracycline
Tétracycline
Tetracycline & VRC3375
Tetracycline (internal use)
Tetracycline (JAN/USP/INN)
Tetracycline [USAN:INN:BAN:JAN]
Tetracycline Free Base
Tetracycline HCl
Tetracycline I
Tetracycline II
Tetracycline Monohydrochloride
Tetracyclinum
Tetracyclinum [INN-Latin]
Tetracyn
Tetradecin
Tetrafil
Tetraverine
Tetrazyklin
Topicycline
Tsiklomistsin
Tsiklomitsin
UNII-F8VB5M810T
UPCMLD-DP127
UPCMLD-DP127:001
UPCMLD-DP127:002
Veracin
Vetacyclinum
Vetquamycin-324 (free base)
WLN: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 MQ M1 RQ
|
|
9 |
|
Lactitol |
Investigational |
Phase 3,Phase 2 |
|
585-86-4 |
3871
|
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
Floralac
|
|
|
10 |
|
PENTA |
|
Phase 3,Phase 2 |
|
|
|
11 |
|
Anti-Bacterial Agents |
|
Phase 3,Phase 2 |
|
|
|
12 |
|
Anti-Infective Agents |
|
Phase 3,Phase 2 |
|
|
|
13 |
|
Altretamine |
Approved |
Phase 2 |
|
645-05-6 |
2123
|
Synonyms:
2,4, 6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylami
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-s-triazine
2,4,6-Tris(dimethylamino)-S-triazine
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
549835_ALDRICH
645-05-6
A 8723
A0567/0026158
A8723_SIGMA
AB00052308
AC-12006
AC1L1CYX
AI3-50852
AKOS001729401
Altretamin
Altretamina
Altretamina [INN-Spanish]
altretamine
Altrétamine
Altretamine (USP/INN)
Altretamine [USAN:INN:BAN]
Altretamine Bellon Brand
Altretamine Chiesi Brand
Altretamine Wassermann Brand
Altretaminum
Altretaminum [INN-Latin]
Bellon Brand of Altretamine
BPBio1_001004
BRD-K67043667-001-04-1
BRN 0195058
BSPBio_000912
C9H18N6
CAS-654-05-6
CCRIS 5492
CHEBI:24564
CHEMBL1455
ChemDiv2_005185
Chiesi Brand of Altretamine
CID2123
CPD000058181
D006585
D02841
DB00488
DivK1c_000772
EINECS 211-428-4
ENT 50852
EU-0100083
FT-0083576
Hemel
Hexalen
Hexalen (TN)
Hexalen, Altretamine
Hexamethylmelamine
HEXAMETHYLMELAMINE
Hexastat
Hexinawas
HMM
HMS1383L15
HMS1570N14
HMS1922C05
HMS2090G17
HMS2092H16
HMS502G14
|
HSDB 7559
HTM
HXM
I06-0604
IDI1_000772
IDI1_003900
InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
KB-913
KBio1_000772
KBio2_001788
KBio2_004356
KBio2_006924
KBio3_002042
KBioGR_001388
KBioSS_001788
Lopac0_000083
Lopac-A-8723
LS-1549
MGI Pharma Brand of Altretamine
MLS000069621
MLS001076123
MolPort-002-111-210
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine
NC 195
NCGC00015100-01
NCGC00015100-02
NCGC00015100-03
NCGC00015100-06
NCGC00015100-11
NCGC00021216-03
NCGC00021216-04
NCGC00021216-05
NCGC00021216-06
NCGC00021216-07
NCI60_000871
NCI-C50259
NINDS_000772
no)-s-triazine
NSC 13875
NSC13875
NSC-13875
Prestwick0_000946
Prestwick1_000946
Prestwick2_000946
Prestwick3_000946
Rhone Poulenc Rorer Brand of Altretamine
Rhone-Poulenc Rorer Brand of Altretamine
S1278_Selleck
SAM002564241
SMR000058181
SPBio_000754
SPBio_003071
Spectrum_001308
SPECTRUM1503065
Spectrum2_000907
Spectrum3_000951
Spectrum4_001064
Spectrum5_001092
ST086739
STK749184
UNII-Q8BIH59O7H
Wassermann Brand of Altretamine
WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1
ZINC00000905
|
|
14 |
|
Daclizumab |
Approved, Investigational |
Phase 2 |
|
152923-56-3 |
|
Synonyms:
|
15 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 2 |
|
83-43-2 |
6741
|
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
1-dehydro-6alpha-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6-alpha-Methylprednisolone
6-Methylprednisolone
83-43-2
AC1L1N7A
Artisone-wyeth
Artisone-Wyeth
Besonia
Bio-0658
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
Lemod
LMST02030178
LS-118498
M0639_SIGMA
M1665
Medesone
Medixon
Medlone 21
Medrate
Medrol
Medrol (TN)
|
Medrol adt pak
Medrol Adt Pak
Medrol dosepak
Medrol Dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
MEPRDL
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
methylprednisolone
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
methylprenisolone
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metilprednisolone [DCIT]
Metipred
Metrisone
Metrocort
Metysolon
MLS000028541
MLS001148159
MLS002207191
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
Nirypan
Noretona
NSC19987
NSC-19987
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick_622
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Promacortine
Reactenol
S1733_Selleck
SAM002589984
Sieropresol
SMR000058330
Solomet
SPBio_002377
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
|
|
16 |
|
Mycophenolate mofetil |
Approved, Investigational |
Phase 2 |
|
128794-94-5 |
5281078
|
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CellCept
Cellcept (TN)
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
CHEMBL1456
CID5281078
D00752
DB00688
HMS2090A03
HSDB 7436
|
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
mycophenolate mofetil
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
|
|
17 |
|
Mycophenolic acid |
Approved |
Phase 2 |
|
24280-93-1 |
446541
|
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
Melbex
|
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolsäure
Myfortic
|
|
18 |
|
Obinutuzumab |
Approved, Investigational |
Phase 2,Phase 1 |
|
949142-50-1 |
|
Synonyms:
|
19 |
|
Prednisolone |
Approved, Vet_approved |
Phase 2 |
|
50-24-8 |
5755
|
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Bio-0666
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
Codelcortone
Co-Hydeltra
CO-Hydeltra
component of Ataraxoid
component of K-Predne-Dome
Cordrol
Cortalone
Cotogesic
Cotolone
CPD000718761
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
Delta(1)-dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Deltacortenol
Deltacortril
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
Delta-Ef-Cortelan
delta-hydrocortisone
Deltahydrocortisone
Deltasolone
Delta-stab
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
Derpo PD
Dexa-Cortidelt hostacortin H
Dexa-Cortidelt Hostacortin H
Di Adreson F
Di-adreson F
Di-Adreson F
DiAdresonF
Di-Adreson-F
Dicortol
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
EINECS 200-021-7
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
Hostacortin H
HSDB 3385
Hydeltra
Hydeltrasol
Hydeltra-Tba
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
|
Hydroretrocortine
Inflamase Forte
Inflamase Mild
I-Pred
K 1557
Key-Pred
Klismacort
Lentosone
Lite Pred
LMST02030179
LS-7669
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meticortelone
Meti-Derm
Metreton
MLS001304083
MLS002154250
MLS002207037
MolPort-002-507-147
M-Predrol
NCGC00179649-01
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
NSC 9120
NSC9120
NSC9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
PRDL
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
prednisolone
Prednisolone (anhydrous)
Prednisolone (JP15/USP/INN)
Prednisolone [INN:BAN:JAN]
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick_404
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Rolisone
S1737_Selleck
SAM002264639
Scherisolon
SMR000718761
Solone
SPBio_002367
Steran
Sterane
Sterolone
Supercortisol
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-hydrogen
Ultracortene-Hydrogen
UNII-9PHQ9Y1OLM
ZINC03833821
|
|
20 |
|
Prednisone |
Approved, Vet_approved |
Phase 2 |
|
53-03-2 |
5865
|
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
Adasone
AI3-52939
Ancortone
Apo-prednisone
Apo-Prednisone
Betapar
Bicortone
Bio-0649
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
C07370
C21H26O5
Cartancyl
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
CPD001227202
Dacorten
Dacortin
DB00635
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
delta cortelan
Delta Cortelan
Delta E
Delta E.
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
Delta-cortelan
Delta-Cortelan
Deltacortene
delta-Cortisone
Deltacortisone
Delta-cortisone
delta-Cortone
Deltacortone
Delta-cortone
Delta-dome
Delta-Dome
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Diadreson
Di-Adreson
Econosone
EINECS 200-160-3
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
|
HMS1568O15
HMS2090J13
Hostacortin
HSDB 3168
Incocortyl
In-Sone
Juvason
Kortancyl
Liquid Pred
Lisacort
LMST02030180
Lodotra
LS-1325
MEGxm0_000443
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI60_000008
NCI-C04897
Nisona
Nizon
Novoprednisone
NSC 10023
NSC10023
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
Panafcort
Panasol
Paracort
Parmenison
Pehacort
PRD
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone [INN:BAN]
Prednisone Intensol
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick_405
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
Servisone
SK-Prednisone
SMR000718760
SMR001227202
Sone
SPBio_002214
Sterapred
Supercortil
U 6020
Ultracorten
Ultracortene
UNII-VB0R961HZT
Winpred
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Wojtab
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
ZINC03875357
|
|
21 |
|
Anticoagulants |
|
Phase 2 |
|
|
|
22 |
|
Fibrinolytic Agents |
|
Phase 2 |
|
|
|
23 |
|
Antibodies, Monoclonal |
|
Phase 2 |
|
|
|
24 |
|
Immunosuppressive Agents |
|
Phase 2 |
|
|
|
25 |
|
Interleukin-2 |
|
Phase 2 |
|
|
|
26 |
|
Peripheral Nervous System Agents |
|
Phase 2 |
|
|
|
27 |
|
Antibiotics, Antitubercular |
|
Phase 2 |
|
|
|
28 |
|
Antiemetics |
|
Phase 2 |
|
|
|
29 |
|
Anti-Inflammatory Agents |
|
Phase 2 |
|
|
|
30 |
|
Antineoplastic Agents, Hormonal |
|
Phase 2 |
|
|
|
31 |
|
Antitubercular Agents |
|
Phase 2 |
|
|
|
32 |
|
Autonomic Agents |
|
Phase 2 |
|
|
|
33 |
|
Gastrointestinal Agents |
|
Phase 2 |
|
|
|
34 |
|
glucocorticoids |
|
Phase 2 |
|
|
|
35 |
|
Hormone Antagonists |
|
Phase 2 |
|
|
|
36 |
|
Hormones |
|
Phase 2 |
|
|
|
37 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Phase 2 |
|
|
|
38 |
|
Methylprednisolone acetate |
|
Phase 2 |
|
|
|
39 |
|
Methylprednisolone Hemisuccinate |
|
Phase 2 |
|
|
|
40 |
|
Neuroprotective Agents |
|
Phase 2 |
|
|
|
41 |
|
Prednisolone acetate |
|
Phase 2 |
|
|
|
42 |
|
Prednisolone hemisuccinate |
|
Phase 2 |
|
|
|
43 |
|
Prednisolone phosphate |
|
Phase 2 |
|
|
|
44 |
|
Protective Agents |
|
Phase 2 |
|
|
|
45 |
|
gamma-Globulins |
|
Phase 1 |
|
|
|
46 |
|
Immunoglobulins, Intravenous |
|
Phase 1 |
|
|
|
47 |
|
Rho(D) Immune Globulin |
|
Phase 1 |
|
|
|
48 |
|
Acetylcholine |
Approved |
|
|
51-84-3 |
187
|
Synonyms:
Acetyl choline ion
Acetylcholine cation
acetylcholine chloride
Acetylcholine Chloride
Acetylcholinium: acetyl-Choline
|
ACh
Choline acetate
Choline acetate (ester)
O-Acetylcholine
|
|
49 |
|
Adalimumab |
Approved |
|
|
331731-18-1 |
16219006
|
Synonyms:
331731-18-1
Adalimumab
Adalimumab (genetical recombination)
Adalimumab (genetical recombination) (JAN)
Adalimumab (USAN/INN)
adalimumab-adbm
|
adalimumab-atto
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
|
|
50 |
|
Azathioprine |
Approved |
|
|
446-86-6 |
2265
|
Synonyms:
[Methyl(nitroimidazolyl)mercaptopurine]
446-86-6
55774-33-9 (hydrochloride salt)
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine
6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine
6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine
6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]
6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine
6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine
6-(Methyl-p-nitro-5-imidazolyl)thiopurine
6-(Methyl-p-nitro-5-imidazolyl)-thiopurine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine
6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine
6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine
6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine
A 4638
A2593_SIAL
A4638_SIAL
A4638_SIGMA
AB00443544
AB00443544-03
AC1L1DAL
AC1Q3Z1F
AC-4230
AI3-50290
AI-981/34845012
Azamun
Azamun [Czech]
Azanin
Azasan
Azasan (TN)
Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine
Azathioprin
azathioprine
Azathioprine (JP15/USP/INN)
Azathioprine [USAN:INN:BAN:JAN]
Azathioprine sodium
Azathioprine Sodium
Azathioprinum
Azathioprinum [INN-Latin]
Azathiopurine
azatiopr in
Azatioprin
Azatioprina
Azatioprina [INN-Spanish]
Azothioprine
B. W. 57-322
BPBio1_000054
BRD-K32821942-001-05-6
BRD-K60324116-001-01-5
BSPBio_000048
BSPBio_001876
BW 57322
BW 57-322
BW-57-322
C06837
C9H7N7O2S
CAS-446-86-6
CBDivE_013132
CCRIS 62
Ccucol
CHEBI:2948
CHEMBL1542
ChemDiv1_002659
CID2265
cMAP_000046
CPD000427366
Cytostatics
D00238
DB00993
DivK1c_000586
EINECS 207-175-4
EU-0100027
|
FT-0083532
HMS1568C10
HMS1920E17
HMS2091K19
HMS501N08
HMS594I19
HSDB 7084
IDI1_000586
Immuran
Imuran
Imuran (tn)
Imuran (TN)
Imurek
Imurel
KBio1_000586
KBio2_000464
KBio2_002427
KBio2_003032
KBio2_004995
KBio2_005600
KBio2_007563
KBio3_001376
KBio3_002906
KBioGR_000646
KBioGR_002427
KBioSS_000464
KBioSS_002433
Lopac0_000027
Lopac-A-4638
LS-123
Methylnitroimidazolylmercaptopurine
MLS001049307
MolPort-000-745-914
MolPort-000-764-262
MolPort-003-665-485
Muran
NCGC00015060-01
NCGC00015060-02
NCGC00015060-04
NCGC00015060-12
NCGC00090836-01
NCGC00090836-02
NCGC00090836-03
NCGC00090836-04
NCGC00090836-05
NCGC00090836-06
NCGC00094593-01
NCGC00094593-02
NCGC00094593-03
NCI-C03474
NINDS_000586
NSC 39084
NSC39084
NSC-39084
Oprea1_375441
Oprea1_533384
Oprea1_633462
Prestwick_41
Prestwick0_000094
Prestwick1_000094
Prestwick2_000094
Prestwick3_000094
S1721_Selleck
SAM002589938
SDCCGMLS-0065415.P001
SMR000427366
SPBio_000255
SPBio_001987
Spectrum_000064
SPECTRUM1500133
Spectrum2_000068
Spectrum3_000308
Spectrum4_000243
Spectrum5_000848
STK831906
STOCK1S-20293
STOCK1S-27186
Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl)
UNII-MRK240IY2L
WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW
ZINC04258316
|
|
Interventional clinical trials:
(show top 50)
(show all 137)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine |
Unknown status |
NCT02153866
|
Phase 4 |
|
2 |
Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations |
Completed |
NCT01777529
|
Phase 4 |
|
3 |
Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine |
Completed |
NCT02880865
|
Phase 4 |
|
4 |
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis |
Completed |
NCT00731965
|
Phase 4 |
|
5 |
Measles, Mumps, and Rubella (MMR) Immunity in College Students |
Completed |
NCT00962819
|
Phase 4 |
|
6 |
Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases |
Completed |
NCT00126997
|
Phase 4 |
|
7 |
Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine |
Completed |
NCT00313950
|
Phase 4 |
|
8 |
Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine |
Completed |
NCT03160820
|
Phase 4 |
|
9 |
MMR Vaccination Among HIV-infected Adults |
Completed |
NCT02724852
|
Phase 4 |
|
10 |
Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) |
Completed |
NCT00326183
|
Phase 4 |
|
11 |
Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) |
Completed |
NCT00312858
|
Phase 4 |
|
12 |
Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. |
Completed |
NCT00388440
|
Phase 4 |
|
13 |
MMR and Varicella Vaccine in Premature Infants |
Completed |
NCT00156559
|
Phase 4 |
|
14 |
Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children |
Completed |
NCT02253407
|
Phase 4 |
|
15 |
Safety Study of a Refrigerator-stable Formulation of VARIVAX® |
Completed |
NCT00432731
|
Phase 4 |
|
16 |
Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV |
Completed |
NCT00329251
|
Phase 4 |
|
17 |
Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts |
Recruiting |
NCT03183765
|
Phase 4 |
Measles-Mumps-Rubella Vaccine |
18 |
Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines |
Recruiting |
NCT03368495
|
Phase 4 |
|
19 |
Homeopathic Vaccine Trial |
Recruiting |
NCT02825368
|
Phase 4 |
|
20 |
Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients |
Recruiting |
NCT01770119
|
Phase 4 |
|
21 |
Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR |
Active, not recruiting |
NCT02325310
|
Phase 4 |
|
22 |
Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination |
Not yet recruiting |
NCT03350698
|
Phase 4 |
|
23 |
Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines |
Terminated |
NCT00138255
|
Phase 4 |
|
24 |
Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants |
Unknown status |
NCT01763268
|
Phase 2, Phase 3 |
|
25 |
Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants |
Completed |
NCT02692599
|
Phase 3 |
|
26 |
Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older |
Completed |
NCT02058563
|
Phase 3 |
|
27 |
A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) |
Completed |
NCT00092391
|
Phase 3 |
|
28 |
Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases |
Completed |
NCT00127023
|
Phase 3 |
|
29 |
Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases |
Completed |
NCT00127010
|
Phase 3 |
|
30 |
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers |
Completed |
NCT01188343
|
Phase 3 |
|
31 |
Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) |
Completed |
NCT01536405
|
Phase 3 |
|
32 |
Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. |
Completed |
NCT01991899
|
Phase 3 |
|
33 |
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life |
Completed |
NCT01681992
|
Phase 3 |
|
34 |
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age |
Completed |
NCT02184572
|
Phase 3 |
|
35 |
Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) |
Completed |
NCT00092430
|
Phase 3 |
|
36 |
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age |
Completed |
NCT01621802
|
Phase 3 |
|
37 |
Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 |
Completed |
NCT00751348
|
Phase 3 |
|
38 |
Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children |
Completed |
NCT00192491
|
Phase 3 |
|
39 |
Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children |
Completed |
NCT00197015
|
Phase 3 |
|
40 |
Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox |
Completed |
NCT00226499
|
Phase 3 |
|
41 |
Immunogenicity and Safety Study of PriorixTetraâ„¢ When Co-administered With Conjugated MenC Vaccine in Healthy Children |
Completed |
NCT01506193
|
Phase 3 |
|
42 |
ProQuadâ„¢ Versus M-M-R IIâ„¢ and VARIVAXâ„¢ in Healthy Children (V221-009)(COMPLETED) |
Completed |
NCT00975507
|
Phase 3 |
|
43 |
Safety Study of ProQuad® rHA in Infants (V221-037) |
Completed |
NCT00560755
|
Phase 3 |
|
44 |
Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM |
Completed |
NCT00969436
|
Phase 3 |
|
45 |
Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly |
Completed |
NCT00432042
|
Phase 3 |
|
46 |
Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine |
Completed |
NCT00406211
|
Phase 3 |
|
47 |
Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix®) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R®II), in Children 12 to 15 Months of Age |
Completed |
NCT01702428
|
Phase 3 |
|
48 |
Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) |
Completed |
NCT00985153
|
Phase 3 |
|
49 |
A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) |
Completed |
NCT00985166
|
Phase 3 |
|
50 |
Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers |
Completed |
NCT00422292
|
Phase 3 |
|
Cochrane evidence based reviews: mumps
|